Literature DB >> 18781894

Eph/ephrin signalling and function in oncogenesis: lessons from embryonic development.

Peter W Janes1, Samantha Adikari, Martin Lackmann.   

Abstract

Eph receptors and their membrane-bound ephrin ligands are developmental cell guidance cues that direct cell migration and orchestrate patterning processes by modulating adhesive or repulsive cell properties. During the past two decades, an exponentially growing interest in their function has resulted in a considerably advanced understanding of the cellular and molecular principles of Eph function in normal and oncogenic development. Ephs not only accurately guide the path of migrating cells, but also facilitate contact and communication between neighbouring cell populations, in particular at epithelial/mesenchymal boundaries. Precise cell positioning not only relies on accurately-graded expression of individual Eph/ephrin pairs, but on the sum of interactions within particular expression domains and their modulation through crosstalk with a range of other signalling systems. There is little doubt that Eph and ephrins provide exciting new targets for anti-cancer therapies, but in appreciation of the complexity of their signals and biological functions it is perhaps not surprising that the development of Eph-specific therapeutics is only emerging.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18781894     DOI: 10.2174/156800908785699315

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  18 in total

Review 1.  Therapeutic targeting of EPH receptors and their ligands.

Authors:  Andrew W Boyd; Perry F Bartlett; Martin Lackmann
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

Review 2.  Eph-dependent cell-cell adhesion and segregation in development and cancer.

Authors:  Eva Nievergall; Martin Lackmann; Peter W Janes
Journal:  Cell Mol Life Sci       Date:  2011-12-28       Impact factor: 9.261

3.  Eph-ephrin bidirectional signaling comes into the context of lymphocyte transendothelial migration.

Authors:  Eva M Trinidad; Agustín G Zapata; Luis M Alonso-Colmenar
Journal:  Cell Adh Migr       Date:  2010-07-22       Impact factor: 3.405

4.  Sensitivity and resistance towards isoliquiritigenin, doxorubicin and methotrexate in T cell acute lymphoblastic leukaemia cell lines by pharmacogenomics.

Authors:  Mahmoud Youns; Yu-Jie Fu; Yuan-Gang Zu; Anne Kramer; V Badireenath Konkimalla; Bernhard Radlwimmer; Holger Sültmann; Thomas Efferth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-07-29       Impact factor: 3.000

5.  Eph receptors and ephrin ligands: important players in angiogenesis and tumor angiogenesis.

Authors:  Birgit Mosch; Bettina Reissenweber; Christin Neuber; Jens Pietzsch
Journal:  J Oncol       Date:  2010-03-10       Impact factor: 4.375

6.  Coexistence of Eph receptor B1 and ephrin B2 in port-wine stain endothelial progenitor cells contributes to clinicopathological vasculature dilatation.

Authors:  W Tan; J Wang; F Zhou; L Gao; R Yin; H Liu; A Sukanthanag; G Wang; M C Mihm; D-B Chen; J S Nelson
Journal:  Br J Dermatol       Date:  2017-11-16       Impact factor: 11.113

7.  PTP1B regulates Eph receptor function and trafficking.

Authors:  Eva Nievergall; Peter W Janes; Carolin Stegmayer; Mary E Vail; Fawaz G Haj; Shyh Wei Teng; Benjamin G Neel; Philippe I Bastiaens; Martin Lackmann
Journal:  J Cell Biol       Date:  2010-12-06       Impact factor: 10.539

8.  A high-content cellular senescence screen identifies candidate tumor suppressors, including EPHA3.

Authors:  Jenni Lahtela; Laura B Corson; Annabrita Hemmes; Matthew J Brauer; Sonja Koopal; James Lee; Thomas L Hunsaker; Peter K Jackson; Emmy W Verschuren
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

9.  Expression and Function of Ephrin-B1 and Its Cognate Receptor EphB2 in Human Abdominal Aortic Aneurysm.

Authors:  Aiji Sakamoto; Masaaki Kawashiri; Hatsue Ishibashi-Ueda; Yuka Sugamoto; Tsuyoshi Yoshimuta; Takeo Higashikata; Hitoshi Ogino; Hayato Tada; Tetsuo Konno; Kenshi Hayashi; Masakazu Yamagishi
Journal:  Int J Vasc Med       Date:  2012-07-05

10.  Low Expression of EphB2, EphB3, and EphB4 in Bladder Cancer: Novel Potential Indicators of Muscular Invasion.

Authors:  Tae Ho Lee; Jin Hyung Heo; Ju Yeon Jeong; Gee Hoon Lee; Dong Soo Park; Tae Hoen Kim
Journal:  Yonsei Med J       Date:  2021-08       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.